DuPont Pharmaceuticals
Pharmaceutical ManufacturingUnited States51-200 Employees
DuPont Pharmaceuticals is a United States–based manufacturer operating in the pharmaceutical manufacturing sector, with a mid-sized workforce. It exists within the broader DuPont corporate family, reflecting affiliation with a diversified materials and science company. In June 2026, the organization announced the launch of Tyvek APX in the ASEAN market at the Thailand Safe@Work 2026 event. This development shows ongoing efforts to bring new products to regional markets. Recent reporting also notes significant corporate moves within the wider DuPont organization, including the spin-off of The Chemours Company in June 2026 and regional expansion initiatives such as facility upgrades in Australia and New Zealand. Together, these items illustrate a global footprint with activity across markets in Asia and Oceania, including participation in regional industry events.